Bacteriotherapy in Pediatric Inflammatory Bowel Disease

Completed · Phase 1

Conditions studied: Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis, CD

In brief

In this study, the investigators want to see if Bacteriotherapy (also referred to as stool transplantation) improves the symptoms and decreases inflammation in children with Inflammatory Bowel Disease (IBD). Examples of IBD are Crohn's Disease and Ulcerative Colitis. Additionally, researchers want to learn whether this experimental therapy delays the need for starting additional medications to treat pediatric IBD.

Key facts

Study ID

NCT01757964

Run by

David Suskind

People needed

13

Starts

2012-12-01

Expected to finish

2015-01-01

Last updated by the study team

2017-05-30

Who can join

Age: 12 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children ages 12-21 years old with a diagnosis of mild to moderate Ulcerative Colitis or Crohn's Disease
• Willing parent to donate stool for the transplant

You may not qualify if…

• Severe Disease
• History of intra-abdominal abscess, intra-abdominal fistula or stricturing
• History of other systemic diseases
• The patient has received TNF inhibitors to treat their IBD within two months of transplant

Where it is running

• Seattle Children's Hospital — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.